the current capitalisation is a shadow of it's former self. Over a year and they still have not established any new direction so many holders siting on 90 % or so losses.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025